These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34439875)

  • 21. Evaluation of the Antifungal and Wound-Healing Properties of a Novel Peptide-Based Bioadhesive Hydrogel Formulation.
    Sultan AS; Vila T; Hefni E; Karlsson AJ; Jabra-Rizk MA
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Interactions between the Antimicrobial Peptide P-113 and Living
    Cheng KT; Wu CL; Yip BS; Chih YH; Peng KL; Hsu SY; Yu HY; Cheng JW
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.
    Pathirana RU; Friedman J; Norris HL; Salvatori O; McCall AD; Kay J; Edgerton M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158282
    [No Abstract]   [Full Text] [Related]  

  • 24. How does it kill?: understanding the candidacidal mechanism of salivary histatin 5.
    Puri S; Edgerton M
    Eukaryot Cell; 2014 Aug; 13(8):958-64. PubMed ID: 24951439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
    Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
    [No Abstract]   [Full Text] [Related]  

  • 26. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
    Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histatin 5 inhibits adhesion of C. albicans to Reconstructed Human Oral Epithelium.
    Moffa EB; Mussi MC; Xiao Y; Garrido SS; Machado MA; Giampaolo ET; Siqueira WL
    Front Microbiol; 2015; 6():885. PubMed ID: 26379655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype.
    Fitzgerald-Hughes DH; Coleman DC; O'Connell BC
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2793-800. PubMed ID: 17485506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.
    Kong EF; Tsui C; Boyce H; Ibrahim A; Hoag SW; Karlsson AJ; Meiller TF; Jabra-Rizk MA
    Antimicrob Agents Chemother; 2016 Feb; 60(2):881-9. PubMed ID: 26596951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands.
    O'Connell BC; Xu T; Walsh TJ; Sein T; Mastrangeli A; Crystal RG; Oppenheim FG; Baum BJ
    Hum Gene Ther; 1996 Dec; 7(18):2255-61. PubMed ID: 8953316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histatins: antimicrobial peptides with therapeutic potential.
    Kavanagh K; Dowd S
    J Pharm Pharmacol; 2004 Mar; 56(3):285-9. PubMed ID: 15025852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide.
    Meiller TF; Hube B; Schild L; Shirtliff ME; Scheper MA; Winkler R; Ton A; Jabra-Rizk MA
    PLoS One; 2009; 4(4):e5039. PubMed ID: 19352427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral fluid proteolytic effects on histatin 5 structure and function.
    Helmerhorst EJ; Alagl AS; Siqueira WL; Oppenheim FG
    Arch Oral Biol; 2006 Dec; 51(12):1061-70. PubMed ID: 16901460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
    Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
    J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Internalisation and degradation of histatin 5 by Candida albicans.
    Ruissen AL; Groenink J; Krijtenberg P; Walgreen-Weterings E; van 't Hof W; Veerman EC; Nieuw Amerongen AV
    Biol Chem; 2003 Jan; 384(1):183-90. PubMed ID: 12674513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human salivary histatins: promising anti-fungal therapeutic agents.
    Tsai H; Bobek LA
    Crit Rev Oral Biol Med; 1998; 9(4):480-97. PubMed ID: 9825223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane.
    Veerman EC; Valentijn-Benz M; Nazmi K; Ruissen AL; Walgreen-Weterings E; van Marle J; Doust AB; van't Hof W; Bolscher JG; Amerongen AV
    J Biol Chem; 2007 Jun; 282(26):18831-41. PubMed ID: 17485465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidacidal activity of human salivary histatin recombinant variants produced by site-directed mutagenesis.
    Driscoll J; Duan C; Zuo Y; Xu T; Troxler R; Oppenheim FG
    Gene; 1996 Oct; 177(1-2):29-34. PubMed ID: 8921841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis.
    Ikonomova SP; Moghaddam-Taaheri P; Wang Y; Doolin MT; Stroka KM; Hube B; Karlsson AJ
    Protein Sci; 2020 Feb; 29(2):480-493. PubMed ID: 31675138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.